首页> 外文期刊>Annals of Medicine and Surgery >Hepatic arterial and portal venous complications after adult and pediatric living donor liver transplantation, risk factors, management and outcome (A retrospective cohort study)
【24h】

Hepatic arterial and portal venous complications after adult and pediatric living donor liver transplantation, risk factors, management and outcome (A retrospective cohort study)

机译:成年和小儿活体供体肝移植后的肝动脉和门静脉并发症,危险因素,管理和结果(回顾性队列研究)

获取原文
           

摘要

Objectives Hepatic arterial (HA) and portal venous (PV) complications of recipients after living donor liver transplantation(LDLT) result in patient loss. The aim of this study was to analyze these complications. Methods We retrospectively analyzed HA and/or PV complications in 213 of 222 recipients underwent LDLT in our centre. The overall male/female and adult/pediatric ratios were 183/30 and 186/27 respectively. Results The overall incidence of HA and/or PV complications was 19.7% (n?=?42), while adult and pediatric complications were 18.3% (n?=?39) and 1.4% (n?=?3) respectively. However early ( 1month) complications were 9.4% (n?=?20) and 10.3% (n?=?22) respectively. Individually HA problems (HA stenosis, HA thrombosis, injury and arterial steal syndrome) 15% (n?=?32), PV problems (PV thrombosis and PV stenosis) 2.8% (n?=?6) and simultaneous HA and PV problems 1.9% (n?=?4). 40/42 of complications were managed by angiography (n?=?18), surgery (n?=?10) or medically (Anticoagulant and/or thrombolytic) (n?=?12) where successful treatment occurred in 18 patients. 13/42 (31%) of patients died as a direct result of these complications. Preoperative PVT was significant predictor of these complications in univariate analysis. The 6-month, 1-, 3-, 5- 7- and 10-year survival rates in patients were 65.3%, 61.5%, 55.9%, 55.4%, 54.5% and 54.5% respectively. Conclusion HA and/or PV complications specially early ones lead to significant poor outcome after LDLT, so proper dealing with the risk factors like pre LT PVT (I.e. More intensive anticoagulation therapy) and the effective management of these complications are mandatory for improving outcome. Highlights ? Preoperative PVT was significant predictor of HA and/or PV complications. ? HA and/or PV complications especially early ones lead to significant poor outcome. ? Proper dealing with the risk factors like pre LT PVT improves outcome. ? The effective management of these complications is mandatory for improving outcome.
机译:目的活体供体肝移植(LDLT)后接受者的肝动脉(HA)和门静脉(PV)并发症导致患者流失。这项研究的目的是分析这些并发症。方法我们回顾性分析了本中心222名接受LDLT的接受者中213名的HA和/或PV并发症。总体男女比例分别为183/30和186/27。结果HA和/或PV并发症的总发生率为19.7%(n?=?42),而成人和儿科并发症分别为18.3%(n?=?39)和1.4%(n?=?3)。然而,早期(1个月)并发症分别为9.4%(n = 20)和10.3%(n = 22)。单独的HA问题(HA狭窄,HA血栓形成,损伤和动脉盗血综合征)为15%(n?=?32),PV问题(PV血栓形成和PV狭窄)2.8%(n?=?6)以及同时的HA和PV问题1.9%(n≤4)。通过血管造影(n = 18),手术(n = 10)或医疗(抗凝和/或溶栓治疗)(n = 12)的并发症处理了40/42例,其中成功治疗18例。这些并发症的直接结果是有13/42(31%)的患者死亡。术前PVT是单因素分析中这些并发症的重要预测指标。患者的6个月,1、3、5-7和10年生存率分别为65.3%,61.5%,55.9%,55.4%,54.5%和54.5%。结论HA和/或PV并发症特别是早期并发症会导致LDLT后明显不良结果,因此必须正确处理LT PVT之前的风险因素(即加强抗凝治疗)和有效处理这些并发症是改善结局的必要条件。强调 ?术前PVT是HA和/或PV并发症的重要预测指标。 ? HA和/或PV并发症,尤其是早期并发症,导致严重不良后果。 ?正确处理LT PVT前等风险因素可改善结局。 ?这些并发症的有效管理对于改善预后是必不可少的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号